Research Article
Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn’s Disease
Table 4
The interaction of genetic and environmental factors for response to IFX after 1 year of treatment of CD patients.
| ||||||||||||||||||||||||
Factors were statistically analyzed by multivariate logistic regression analysis. IFX: infliximab; CD: Crohn’s disease; OR: odds ratio; CI: confidence interval. |